CanSino Biologics Has First COVID-19 Vaccine to Reach Phase 2
by Brian Wang from NextBigFuture.com on (#5244S)
CanSino Biologics is starting phase II clinical trials for Ad5-nCoV, a COVID-19 vaccine candidate. Ad5-nCoV is a genetic engineered vaccine candidate with the replication-defective adenovirus type 5...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]